Author guidelines

Infinity Journal of Medicine and Innovation (IJMI) is peer-review journal. Manuscripts must be submitted via the online submission system by registered users. Registration is straightforward and accessible through the journal’s platform.

IJMI welcomes five article types: (1) Original Articles (basic medical research, clinical research, or community-based research); (2) Case Reports; (3) Review Articles; (4) perspective; (5) Letter to the Editor.

Benefits for Authors

Publishing in the Infinity Journal of Medicine and Innovation (IJMI) offers authors several advantages:

  • Free of charge: IJMI is a fully open-access journal with no article processing charges (APCs) or submission fees.
  • Global visibility: All published articles are freely accessible worldwide, ensuring wide dissemination of research.
  • Double-blind peer review: All manuscripts undergo a fair and objective review process by expert reviewers within short time.
  • Plagiarism screening: Submissions are checked using advanced plagiarism detection tools to ensure originality and scientific integrity.
  • Modern online platform: The journal operates through Open Journal Systems (OJS), providing authors with a secure and user-friendly interface for submission and tracking.
  • Electronic publication: The journal is published exclusively online and adheres to international publishing standards.
  • Responsive editorial support: Authors receive timely updates and personalized support throughout the submission and review process.
  • Transparent communication: Authors may communicate anonymously with peer reviewers through the secure OJS platform.

IJMI is committed to fostering scientific excellence and supporting early-career and established researchers in medicine and innovation.

Manuscript Instructions

For Original Articles

IJMI follows the “IMRAD” structure (Introduction, Methods, Results, and Discussion). Manuscripts should include:

Title Page:

  • The title (specific, informative, concise; max 150 characters, including spaces).
  • Each author’s highest academic degree and institutional affiliation (department/institute/organization).
  • Corresponding author’s mailing address, telephone number, and email (mandatory).

Abstract:

  • Up to 250 words, structured as:
    • Background: Rationale for the study.
    • Objective: Study aim.
    • Subjects and Methods: Key procedures (study setting, participant selection, measurements, analytical methods).
    • Results: Main findings with specific effect sizes, statistical/clinical significance where applicable.
    • Conclusion: Highlight new, significant findings without overinterpretation.
  • Keywords: 3–5 terms.

Introduction:

  • Concisely outline the motivation and research background (not an exhaustive review).
  • State the study’s aim and primary/secondary objectives in one paragraph, avoiding results or conclusions.

Subjects and Methods:

  • Detail the study protocol: design, setting, duration, sample group (eligibility, inclusion/exclusion criteria), interventions, and investigations.
  • Specify ethical approval from relevant committees.
  • Include specifications (manufacturer, city, country) for drugs, chemicals, and instruments.
  • Describe statistical methods, significance levels, terms, abbreviations, and software (with version).
  • Cite questionnaire sources without including them in the manuscript.
  • For clinical trials, include the CONSORT flow diagram as a figure and provide registration numbers on the title page.

Results:

  • Present findings logically, prioritizing key outcomes.
  • Use tables (up to 4) and figures (up to 4) to summarize data, avoiding duplication with text.
  • Provide absolute numbers alongside derivatives (e.g., percentages) and use statistical measures (e.g., standard deviation, confidence intervals) with significance levels.

Discussion:

  • Avoid repeating data from other sections.
  • Summarize key findings, explore mechanisms/explanations, and compare with existing evidence.
  • Address study limitations and implications for future research or clinical practice.

Conclusion:

  • Align with study goals, avoiding unsupported claims or overstatements (e.g., economic impacts without data).
  • Suggest clear, simple recommendations if applicable.

References:

  • 20–40 references in Vancouver style, with at least 60% from the last five years.
  • Number consecutively in order of appearance in text (e.g., [1]), listing up to six authors before “et al.”
  • Example:
    • Journal: Sharma A, Yadav A, Nandy A, Ghatak S. Insight into the functional dynamics and challenges of exosomes in pharmaceutical innovation and precision medicine. Pharmaceutics. 2024;16:709.
    • Book Chapter: Smith J. Pediatric Neurology. In: Smith J, Advances in Child Health, 3rd ed. New York (NY): Elsevier; 2020, p. 123-145.

For Case Reports

Title Page: Same as original articles, with 3–5 keywords.

Abstract: Up to 200 words, non-structured: Background, Case Presentation, Investigations, Treatment, Outcome and Follow-Up, Conclusion.

Introduction: Explain the reason for reporting the case.

Case Presentation: Detail the case as known at presentation. Investigations: List tests in logical sequence. Treatment: Describe interventions chronologically. Outcome and Follow-Up: Report primary outcomes and long-term follow-up if available. Discussion and Conclusion: Compare with literature and summarize key points.

References: 5–10 references.

  • Include relevant figures where possible.

For Review Articles

  • Narrative reviews should critically assess current knowledge, cover recent literature comprehensively, and be authored by experts.
  • Format mirrors full papers (abstract, introduction, etc.), but sections like Methods/Results are optional.
  • Minimum 60 references required.

For Letters to the Editor

  • Max 750 words, submitted within 4 months of the discussed article’s publication.
  • Peer-reviewed and edited for clarity.
  • Up to 5 references.

Ethical Considerations

IJMI is applying for Committee on Publication Ethics (COPE) membership and follows COPE guidelines for ethical issues, alongside ICMJE recommendations.

  • Human and Animal Rights: Research must comply with the Declaration of Helsinki.
  • Informed Consent: Written consent from participants or guardians is required. IJMI may request related documents.
  • Conflict of Interest: Authors must disclose any financial, personal, or other conflicts.
  • Plagiarism: Verbatim use of prior work is prohibited; COPE guidelines apply if detected.
  • Data Fabrication/Falsification: Use of falsified or fabricated data is forbidden.
  • Image Manipulation: Only original images are encouraged; adjustments must not alter meaning. Editors may request original data if manipulation is suspected.

Copyright

Authors must secure permission for previously published material and submit original permission letters.

Submission Requirements

  1. Cover Letter: Confirm no concurrent submissions and disclose related publications.
  2. Title Page: Include title, authors, institution, running title, and corresponding author details (unnumbered).
  3. Photo Clinics: High-quality figures (1–2) with a 500-word description; up to 5 references.
  4. Tables and Figures: Cite in order (Arabic numerals), max 4 each. Submit high-resolution images (jpeg/bitmap). Legends on a separate page.
  5. Supplementary Materials: Movie clips, questionnaires, etc., may appear online.

Language and Style

  • Use American or British English, clear and concise.
  • Double-spaced, numbered pages.
  • Limit abbreviations to standard terms, explained at first use.
  • Editorial office may edit for style; authors remain responsible for content.

Copyright and Licensing

IJMI uses the CC BY 4.0 license, allowing authors to retain copyright while permitting reuse with proper attribution.

Privacy Statement

Names and email addresses are used solely for journal purposes and not shared otherwise.

Plagiarism Policy

The Infinity Journal of Medicine and Innovation (IJMI) strictly prohibits all forms of plagiarism and is committed to maintaining high standards of academic integrity. All submitted manuscripts undergo a thorough similarity check using professional plagiarism detection software (Turnitin) before entering the peer review process.

IJMI accepts a maximum similarity index of 15%, excluding references and common phrases. Furthermore, no single source should exceed 2% of similarity. Manuscripts exceeding these thresholds will be automatically rejected or returned to the authors for revision.

Plagiarism includes, but is not limited to:

  • Copying text, figures, or ideas from another work without proper attribution.

  • Submitting someone else's work as one’s own.

  • Self-plagiarism (reusing significant parts of previously published content without citation).

IJMI is fully dedicated to upholding research ethics and ensuring that all publications are original, ethically sound, and contribute meaningfully to scientific knowledge.